SIE

206.4

-2.85%↓

AIR.FR

161.88

-2.63%↓

ENR.DE

145.85

-1.85%↓

RHM

1,440.5

-4.76%↓

HO

236.5

-2.63%↓

SIE

206.4

-2.85%↓

AIR.FR

161.88

-2.63%↓

ENR.DE

145.85

-1.85%↓

RHM

1,440.5

-4.76%↓

HO

236.5

-2.63%↓

SIE

206.4

-2.85%↓

AIR.FR

161.88

-2.63%↓

ENR.DE

145.85

-1.85%↓

RHM

1,440.5

-4.76%↓

HO

236.5

-2.63%↓

SIE

206.4

-2.85%↓

AIR.FR

161.88

-2.63%↓

ENR.DE

145.85

-1.85%↓

RHM

1,440.5

-4.76%↓

HO

236.5

-2.63%↓

SIE

206.4

-2.85%↓

AIR.FR

161.88

-2.63%↓

ENR.DE

145.85

-1.85%↓

RHM

1,440.5

-4.76%↓

HO

236.5

-2.63%↓

Search

HOCHTIEF AG

Atidarymo kaina

SektoriusPramonės sektorius

390.2 -4.13

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

387.8

Max

410.6

Pagrindiniai rodikliai

By Trading Economics

Pajamos

72M

247M

Pardavimai

388M

10B

Pelnas, tenkantis vienai akcijai

4.09

Dividendų pajamingumas

3.17

Pelno marža

2.436

Rekomendacijos

By TipRanks

Rekomendacijos

Neutralu

12 mėnesių prognozė

-16.44% downside

Dividendai

By Dow Jones

Dividendų pajamingumas

Sektoriaus vid.

3.17%

2.23%

Kitas uždarbis

2026-05-11

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

4.7B

Ankstesnė atidarymo kaina

394.33

Ankstesnė uždarymo kaina

390.2

Naujienos nuotaikos

By Acuity

50%

50%

177 / 406 reitingas Industrials

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Very Strong Bearish Evidence

HOCHTIEF AG Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-03-23 23:47; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences to Buy Ouro Medicines, Collaborate With Galapagos on Purchased Assets -- Update

2026-03-23 22:55; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences to Buy Ouro Medicines for Up to $2.18 Billion

2026-03-23 21:51; UTC

Įsigijimai, susijungimai, perėmimai

Italy's Postal Service Makes $12.50 Billion Bid for Telecom Italia -- 3rd Update

2026-03-23 23:59; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2026-03-23 23:59; UTC

Rinkos pokalbiai

Woodside, Santos Earnings Power Up on Surging LNG Prices -- Market Talk

2026-03-23 23:50; UTC

Rinkos pokalbiai

Nikkei May Rise on Hopes for U.S. Talks With Iran -- Market Talk

2026-03-23 23:37; UTC

Rinkos pokalbiai

Gold Rises, Boosted by Fall in Dollar, U.S. Treasury Yields -- Market Talk

2026-03-23 22:42; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Global Equities Roundup: Market Talk

2026-03-23 22:42; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Bell Potter Names Miners Less Exposed to Fuel Price, Supply Risks -- Market Talk

2026-03-23 22:40; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences to Buy Ouro Medicines for Up to $2.18B

2026-03-23 22:23; UTC

Rinkos pokalbiai

Apollo Debt Solutions Shrugs Off Private-Credit Fears -- Market Talk

2026-03-23 22:22; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences: OM336 Is for Treatment of Autoantibodies Driven Immune-Mediated Disease

2026-03-23 22:21; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences: Company Would Pay Galapagos Royalties of 20%-23% of Net OM336 Sales

2026-03-23 22:21; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences: Company Would Retain Sole Worldwide Commercialization Rights of OM336 Outside of Greater China

2026-03-23 22:20; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences: Company, Galapagos Would Collaborate on Development of OM336 >GILD

2026-03-23 22:20; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences: Galapagos Would Absorb Substantially All of Ouro's Operating Assets, Retain Its Employees >GILD

2026-03-23 22:19; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences: Galapagos Would Pay 50% of Upfront Consideration and 50% of Any Contingent Milestone Payments Payable to Ouro Shareholders

2026-03-23 22:19; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences: Currently in Advanced Discussions With Galapagos With Respect to Potential Research-and-Development Collaboration on Acquired Ouro Assets

2026-03-23 22:18; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences to Buy Ouro Medicines for About $1.68B Upfront, Up to $500M in Contingent Milestone Payments >GILD

2026-03-23 22:15; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences To Acquire Ouro Medicines To Advance First In Class T Cell Engager Program For Autoimmune Diseases >GILD

2026-03-23 22:08; UTC

Rinkos pokalbiai

Ebos Needs to Reset Its Gearing Targets -- Market Talk

2026-03-23 21:42; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2026-03-23 21:42; UTC

Rinkos pokalbiai

RBNZ's Breman Strikes Reassuring Tone On Rates -- Market Talk

2026-03-23 21:32; UTC

Uždarbis

WuXi XDC Cayman: Results Aided by Strong Growth in Contract Research, Development and Manufacturing Organisation Business>2268.HK

2026-03-23 21:32; UTC

Uždarbis

WuXi XDC Cayman 2025 Net CNY1.56B Vs. Net CNY917.16M >2268.HK

2026-03-23 21:32; UTC

Uždarbis

WuXi XDC Cayman 2025 Rev CNY5.94B Vs. CNY4.05B >2268.HK

2026-03-23 21:10; UTC

Svarbiausios naujienos

Oil Is Back Under $100. Trump Says Iran Has Agreed to No Nuclear Weapons. -- Barrons.com

2026-03-23 20:50; UTC

Rinkos pokalbiai

Tech, Media & Telecom Roundup: Market Talk

2026-03-23 20:50; UTC

Rinkos pokalbiai

Health Care Roundup: Market Talk

2026-03-23 20:50; UTC

Rinkos pokalbiai
Uždarbis
Svarbiausios naujienos

Basic Materials Roundup: Market Talk

Akcijų palyginimas

Kainos pokytis

HOCHTIEF AG Prognozė

Kainos tikslas

By TipRanks

-16.44% į apačią

12 mėnesių prognozė

Vidutinis 329.57 EUR  -16.44%

Aukščiausias 387 EUR

Žemiausias 296 EUR

Remiantis 4 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines HOCHTIEF AG kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Neutralu

4 ratings

0

Pirkti

3

Laikyti

1

Parduoti

Techninis įvertinimas

By Trading Central

159.1 / 167.5Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Very Strong Bearish Evidence

Vidutinės trukmės periodas

Bearish Evidence

Ilgalaikis periodas

Bullish Evidence

Rinkos nuotaikos

By Acuity

177 / 406 reitingas Pramonės sektorius

Naujienos nuotaikos

Neutral

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

Veiklos pelnas

$

Apie bendrovę HOCHTIEF AG

There is no Profile data available for HOT.BE.
help-icon Live chat